Fundus Camera Market to Surpass US$ 554.8 Mn by 2030

Global Fundus Camera Market, by Product Type (Mydriatic Fundus, Non Retractable Fundus, Hybrid Fundus Cameras, Retinopathy of Prematurity (ROP) Fundus Cameras), by Modality (Stationary/Tabletop, Mobile), by End User (Hospitals, Ophthalmology Clinics, Ophthalmic and Optometrist Offices, Others ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa), is estimated to be valued at US$ 365.4 million in 2022, and is expected to exhibit a CAGR of 5.4% during the forecast period (2022-2030).

Increasing number of distribution agreements between market players is expected to boost the market growth over forecast period. For instance, in April 2021, MellingMedical, a CVE (Center for Verification and Evaluation)-Verified Service Disabled Veteran-Owned Small Business (SDVOSB) announced a distribution agreement with, Optomed, health care technology company. Under the distribution agreement, MellingMedical will deliver Optomed's Aurora IQ camera to federal health facilities across the country. Aurora IQ is a handheld fundus camera with integrated artificial intelligence for faster eye screening.

Increase in the number of awareness programs regarding eye care by nonprofit organizations is expected to propel growth of the global fundus camera market during the forecast period. For instance, on December 6, 2022, Sankar Foundation Eye Hospital, Eye care center in Andhra Pradesh, India organized eye care awareness program for the students studying B. Pharmacy and D. Pharmacy. The awareness program included educating the students about the technological advancements in the field of ophthalmology and the importance of regular eye checkups to improve vision.

Global Fundus Camera Market - Impact of Coronavirus (COVID – 19) Pandemic

The COVID-19 pandemic has affected several markets across the globe. The COVID-19 pandemic has affected demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and due to its financial impact on firms and financial markets. Thus, Coronavirus (COVID-19) pandemic is expected to negatively impact growth of the global fundus camera market during the forecast period. For instance, according to the Indian Journal of Ophthalmology, May 2021, a cross-sectional observational study was conducted on patients affected by COVID-19. The study included patients with no, mild, and moderate symptoms. Fundus examination using indirect ophthalmoscopy and fundus imaging of each patient using a nonmydriatic handheld fundus camera was done. It was found that COVID-19 patients with mild-to-moderate symptoms did not show any inflammatory/infective or vaso-occlusive lesions in the retina attributable to COVID-19 infection.

Browse 25 Market Data Tables and 21 Figures spread through 156 Pages and in-depth TOC on Global Fundus Camera Market Global Fundus Camera Market, by Product Type (Mydriatic Fundus, Non Retractable Fundus, Hybrid Fundus Cameras, Retinopathy of Prematurity (ROP) Fundus Cameras), by Modality (Stationary/Tabletop, Mobile), by End User (Hospitals, Ophthalmology Clinics, Ophthalmic and Optometrist Offices, Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa)

To know the latest trends and insights prevalent in the Global Fundus Camera Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/fundus-camera-market-468

Key Takeaways of the Global Fundus Camera Market:

• Global fundus camera market is expected to exhibit a CAGR of 5.4% over the forecast period (2022-2030). North America is expected to account for a major market share over the forecast period (2022-2030), owing to increasing product approvals by regulatory authorities. For instance, on November 15, 2022, AEYE Health, a U.S. based digital health company that provides fully autonomous, AI-based diagnostic screening solutions for retinal imaging received the U.S. FDA 510(k)clearance to market its diagnostic screening system for diabetic retinopathy.
• Stationary/Tabletop segment is expected to account for major market share over the forecast period (2022-2030), owing to increasing agreements by market players. For instance, in April 2022, Thirona B.V., a high-tech company focusing on development and marketing of automated analysis tools for medical images has signed an agreement with iCare, part of Revenio, a company in the global market for ophthalmological devices and software solutions for the integration of Thirona's RetCAD artificial intelligence programme into the iCare solutions for eye disease screening in Europe. RetCAD is a computer-aided detection system that detects abnormalities in the eye
• In terms of end user segment, Hospitals is expected to account for major market share over the forecast period (2022-2030), owing to increase in the number of surgeries related to diabetes retinopathy
• Some of the major players operating in the global fundus camera market include Carl Zeiss AG, Hoya Corporation, Canon Inc., Nidek Co., Ltd., Topcon Corporation, Intelligent Retinal Imaging Systems, Inc., Kowa Company Ltd., Optomed Oy (Ltd.), Vision Equipment Inc., Clarity Medical Systems, Inc., Medimaging Integrated Solution Inc., S4OPTIK LLC., Shenzhen Thondar Technology Co., Ltd., CenterVue SpA